4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001493152-26-010334
CEO & President acquired 25,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Equels Thomas K CEO & President | 2026-03-12 | Conversion | +25,000 | 63,922 | D | ||
| Derivatives | |||||||
| Equels Thomas K CEO & President | 2026-03-12 | Conversion · Series G Convertible Preferred Stock | −25 | 0 | D | ||
Loading xslF345X05/ownership.xml…